NCT01784497

Brief Summary

Health Related Quality of Life Assessment In Egyptian Recipients After Living Donor Liver Transplantation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 2, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 6, 2013

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2014

Completed
Last Updated

October 15, 2014

Status Verified

October 1, 2014

Enrollment Period

1.7 years

First QC Date

February 2, 2013

Last Update Submit

October 12, 2014

Conditions

Health Related Quality of Life

Keywords

Health Related Quality of Life (HRQL)Living Donor Liver Transplantation(LDLT)

Outcome Measures

Primary Outcomes (1)

  • Quality of life after LDLT In Egyptian patients using short form 36 (SF - 36) score.

    6 months

Secondary Outcomes (1)

  • Impact of post transplant medical and psychiatric complications on quality of life

    6 months

Study Arms (1)

Recipients of Living Donor Liver Transplantation

Patients who will undergo Living Donor Liver Transplantation (LDLT) In Ain Shams Center For Organ Transplantation (ASCOT) .

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

patients who will undergo LDLT In Ain Shams Center For Organ Transplantation (ASCOT) in the next 6 months.

You may qualify if:

  • Adult Egyptian patients
  • years old
  • Patients transplanted for HCV related disease and /or HCC
  • Informed consent

You may not qualify if:

  • Other etiologies for end stage liver disease (such as HBV and cholestatic liver disease and autoimmune hepatitis).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams Center For Organ Transplantation (ASCOT),Ain Shams university

Cairo, Egypt

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of tropical medicine , Ain Shams university

Study Record Dates

First Submitted

February 2, 2013

First Posted

February 6, 2013

Study Start

January 1, 2013

Primary Completion

October 1, 2014

Study Completion

October 1, 2014

Last Updated

October 15, 2014

Record last verified: 2014-10

Locations

EG(1)